Article
CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
International journal of cancer - 16 May 1995
Yacyshyn M B, Poppema S, Berg A, MacLean G D, Reddish M A, Meikle A, Longenecker B M
Abstract excerpt
Lymphocyte activation markers CD69 and HLA-DR were studied in metastatic breast and ovarian cancer patients who received active specific immunotherapy (ASI) using cancer vaccines containing the synthetic tumor-associated antigen sialyl-Tn or the Thomsen-Friedenreich antigen conjugated to KLH plus...
Topics
- Adenocarcinoma
- Adult
- Aged
- Antibodies, Monoclonal
- Antigens, CD
- Antigens, Differentiation, T-Lymphocyte
- Antigens, Neoplasm
- Breast Neoplasms
- CD3 Complex
- CD4 Antigens
- CD57 Antigens
- CD8 Antigens
- Female
- HLA-DR Antigens